Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Day One Biopharmaceutical...

    NASDAQ: DAWN · Real-Time Price · USD
    6.64
    -0.03 (-0.45%)
    At close: Jun 16, 2025, 3:59 PM
    6.61
    -0.45%
    After-hours: Jun 16, 2025, 06:54 PM EDT

    Day One Biopharmaceuticals Statistics

    Share Statistics

    Day One Biopharmaceuticals has 101.36M shares outstanding. The number of shares has increased by 15.98% in one year.

    Shares Outstanding

    n/a
    		 101.36M

    Shares Change (YoY)

    n/a
    		 15.98%

    Shares Change (QoQ)

    n/a
    		 0.5%

    Owned by Institutions (%)

    n/a
    		 97.02%

    Shares Floating

    n/a
    		 74.66M

    Failed to Deliver (FTD) Shares

    n/a
    		 2

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 18.56M, so 18.31% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 18.56M

    Short % of Shares Out

    n/a
    		 18.31%

    Short % of Float

    n/a
    		 27.24%

    Short Ratio (days to cover)

    n/a
    		 13.86

    Valuation Ratios

    The PE ratio is -12.42 and the forward PE ratio is -7.93. Day One Biopharmaceuticals's PEG ratio is 0.22.

    PE Ratio

    n/a
    		 -12.42

    Forward PE

    n/a
    		 -7.93

    PS Ratio

    n/a
    		 9.04

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 2.36

    P/FCF Ratio

    n/a
    		 -14.78

    PEG Ratio

    n/a
    		 0.22
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Day One Biopharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 7.66

    Quick Ratio

    n/a
    		 7.61

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $724,646.41

    Profits Per Employee

    n/a
    		 $-527,602.21

    Employee Count

    n/a
    		 181

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 1.59

    Taxes

    Income Tax

    n/a
    		 -7.14M

    Effective Tax Rate

    n/a
    		 8.09%

    Stock Price Statistics

    The stock price has increased by -44.8% in the last 52 weeks. The beta is -1.3, so Day One Biopharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.3

    52-Week Price Change

    n/a
    		 -44.8%

    50-Day Moving Average

    n/a
    		 6.9

    200-Day Moving Average

    n/a
    		 11.14

    Relative Strength Index (RSI)

    n/a
    		 45.52

    Average Volume (20 Days)

    n/a
    		 1,269,074

    Income Statement

    In the last 12 months, Day One Biopharmaceuticals had revenue of 131.16M and earned -95.5M in profits. Earnings per share was -1.02.

    Revenue

    n/a
    		 131.16M

    Gross Profit

    n/a
    		 125.88M

    Operating Income

    n/a
    		 -217.27M

    Net Income

    n/a
    		 -95.5M

    EBITDA

    n/a
    		 -217.27M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.02
    Full Income Statement

    Balance Sheet

    The company has 124.97M in cash and 2.6M in debt, giving a net cash position of 122.37M.

    Cash & Cash Equivalents

    n/a
    		 124.97M

    Total Debt

    n/a
    		 2.6M

    Net Cash

    n/a
    		 122.37M

    Retained Earnings

    n/a
    		 -554.08M

    Total Assets

    n/a
    		 534.36M

    Working Capital

    n/a
    		 460.77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -78.11M and capital expenditures -2.17M, giving a free cash flow of -80.28M.

    Operating Cash Flow

    n/a
    		 -78.11M

    Capital Expenditures

    n/a
    		 -2.17M

    Free Cash Flow

    n/a
    		 -80.28M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 95.98%, with operating and profit margins of -165.65% and -72.81%.

    Gross Margin

    n/a
    		 95.98%

    Operating Margin

    n/a
    		 -165.65%

    Pretax Margin

    n/a
    		 -67.36%

    Profit Margin

    n/a
    		 -72.81%

    EBITDA Margin

    n/a
    		 -165.65%

    EBIT Margin

    n/a
    		 -165.65%

    FCF Margin

    n/a
    		 -61.21%

    Dividends & Yields

    DAWN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DAWN is $32, which is 381.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 381.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.61

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist